Eli Lilly and CompanyLLYNYSE
LOADING
|||
Net Income Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$10.59B
↑ 110% above average
Average (9y)
$5.03B
Historical baseline
Range
High:$10.59B
Low:$-204.10M
CAGR
+17.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $10.59B | +102.1% |
| 2023 | $5.24B | -16.1% |
| 2022 | $6.24B | +11.9% |
| 2021 | $5.58B | -9.9% |
| 2020 | $6.19B | -25.5% |
| 2019 | $8.32B | +157.4% |
| 2018 | $3.23B | +1683.5% |
| 2017 | $-204.10M | -107.5% |
| 2016 | $2.74B | +13.7% |
| 2015 | $2.41B | - |